Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-26 @ 1:36 AM
NCT ID:
NCT01015833
Group ID:
EG000
Title:
Arm I (Doxorubicin Hydrochloride, Sorafenib Tosylate)
Description:
Patients receive 60 mg/m2 doxorubicin hydrochloride IV on day 1 and 400 mg sorafenib tosylate PO QD or BID on days 1-21. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. After 6 courses, patients may continue to receive sorafenib tosylate PO QD or BID in the absence of disease progression or unacceptable toxicity.
Deaths Number Affected:
12
Deaths Number At Risk:
None
Serious Number Affected:
71
Serious Number At Risk:
167
Other Number Affected:
146
Other Number At Risk:
167
Study:
NCT01015833
Results Section:
NCT01015833
Adverse Events Module:
NCT01015833